Results 101 to 110 of about 210,000 (180)

Sideroblastic anemia: An underdiagnosed rare disease

open access: yesPediatric Hematology Oncology Journal, 2022
Swetha Palla   +5 more
doaj   +1 more source

SIDEROBLASTIC ANAEMIA–A HITHERTO UNRCCGNIZED CAUSE OF UNEXPLAINED ANAEMIA

open access: yesPakistan Armed Forces Medical Journal, 2018
Objective: To assess the clinicopathological heterogeneity of sideroblastic anemia disorders characterized by the presence of ring sideroblasts in the bone marrow. Study Design: Descriptive study. Place and Duration of Study: Study was conducted
Kamran Nazir Ahmad   +5 more
doaj  

Biallelic mutations in the SARS2 gene presenting as congenital sideroblastic anemia. [PDF]

open access: yesHaematologica, 2021
Colin E   +13 more
europepmc   +1 more source

A New Gain-of-Function NLRP1 Variant Is Associated with Inflammasome Activation and Disease Severity in SLC25A38 Congenital Sideroblastic Anemia Case Report. [PDF]

open access: yesJ Pers Med
Sánchez-Villalobos M   +11 more
europepmc   +1 more source

Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.

open access: yes, 2000
X-linked sideroblastic anemia (XLSA) is caused by mutations in the erythroid-specific 5-aminolevulinic acid synthase (ALAS2) gene. An elderly woman who presented with an acquired sideroblastic anemia is studied.
CAZZOLA, MARIO   +5 more
core  

Sideroblastic Anemias

open access: yes, 2018
Nathan T. Connell, Edward J. Benz
openaire   +1 more source

Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia. [PDF]

open access: yesBlood Adv, 2022
Morimoto Y   +11 more
europepmc   +1 more source

COVID-19 associated respiratory failure complicating a pericardial effusion in a patient with sideroblastic anemia. [PDF]

open access: yesRespir Med Case Rep, 2021
Sayad E   +5 more
europepmc   +1 more source

[Sideroblastic anemia].

open access: yes[Rinsho ketsueki] The Japanese journal of clinical hematology, 1973
M, Tsukada, M, Shimizu
openaire   +4 more sources

Erworbene vitamin-B₆-responsive, primäre sideroblastische Anämie, ein Enzymdefekt der Hämsynsthese

open access: yes, 1981
The activity of delta-aminolevulinic acid synthetase (ALAS), the rate-limiting enzyme in heme synthesis, has been found to be markedly reduced (13% of controls) in erythroblasts of a patient with acquired, primary sideroblastic anemia.
Giger, U.   +3 more
core  

Home - About - Disclaimer - Privacy